IP Library Granted Patent US 11,576,594
Granted Patent B2
US 11,576,594 · App. 16/560,555 · Granted Feb 14, 2023

Insulin pump based expert system

Inventor: Michael Blomquist (Blaine, MN)
Assignee: Tandem Diabetes Care, Inc.
A61B5/14532A61B5/4839A61B5/7475A61M5/1723G16H10/20G16H20/17G16H40/63G16H40/67G16H50/20A61B5/7275A61B2560/045A61M2005/14208A61M2205/3561A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,576,594
App. No.
16/560,555
Granted
Feb 14, 2023
Kind
B2
Abstract

An apparatus including a controller can determine a rate of change of a blood glucose level of a subject from blood glucose data and determine if there is a risk of the blood glucose level going high or low.

Claims (36)

1. A system comprising:

a pump configured to deliver insulin;

an input configured to receive sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection; and

a controller communicatively coupled to the pump and the input, the controller configured to:

monitor the sensor glucose data from the continuous glucose monitor;

determine a rate of change of the blood glucose level and a current glucose level of the user from the sensor glucose data;

compare the current glucose level of the user and the rate of change of the blood glucose level to a predetermined high glucose level;

determine that a correction bolus should be delivered when the current glucose level of the user is not over the predetermined high glucose level but the rate of change indicates that there is a risk of the user going over the predetermined high glucose level in the future;

automatically calculate the correction bolus; and

cause the pump to deliver the correction bolus to the user.

2. The system of claim 1 , wherein the controller is configured to automatically deliver the correction bolus.

3. The system of claim 1 , wherein the controller is further configured to present a recommendation to deliver the correction bolus on a user interface and to deliver the correction bolus only after receiving a confirmation in response to the recommendation.

4. The system of claim 1 , wherein the controller is configured to determine, based on a current blood glucose level of the user and the rate of change of the blood glucose level, that a correction bolus should be delivered if the blood glucose level is high and increasing at a certain rate.

5. The system of claim 1 , wherein the controller is further configured to provide a notification to the user regarding the correction bolus.

6. The system of claim 1 , wherein the controller, the input and the pump are part of a common device.

7. The system of claim 1 , wherein the controller and the input are part of a handheld device that is separate from the pump.

8. A system comprising:

a pump configured to deliver insulin;

an input configured to receive sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection; and

a controller communicatively coupled to the pump and the input, the controller configured to:

monitor the sensor glucose data from the continuous glucose monitor;

determine a rate of change of the blood glucose level of the user and a current glucose level from the sensor glucose data;

compare the current glucose level of the user and the rate of change of the blood glucose level to a target glucose level;

determine that a current insulin delivery pattern should be modified based on the current glucose level of the user and the rate of change of the blood glucose level;

automatically calculate a modification to the insulin delivery pattern; and

cause the pump to employ the modified insulin delivery pattern.

9. The system of claim 8 , wherein the target glucose level is a predetermined high glucose level, and the controller is configured to determine that the current insulin delivery pattern should be modified when the current glucose level of the user is not over the predetermined high glucose level but the rate of change indicates that there is a risk of the user going over the predetermined high glucose level in the future.

10. The system of claim 9 , wherein when the controller determines that the current insulin delivery pattern should be modified, the controller is configured to calculate the modification to the insulin delivery pattern by calculating an insulin correction bolus.

11. The system of claim 8 , wherein the target glucose level is a predetermined low glucose level, and the controller is configured to determine that the current insulin delivery pattern should be modified when the current glucose level of the user is not below the predetermined low glucose level but the rate of change indicates that there is a risk of the user going below the predetermined low glucose level in the future.

12. The system of claim 11 , wherein when the controller determines that the current insulin delivery pattern should be modified, the controller is configured to calculate the modification to the insulin delivery pattern by reducing an amount of insulin delivered.

13. The system of claim 8 , wherein the controller comparing the current glucose level to a target glucose level includes comparing the current glucose level to a target range of glucose levels.

14. The system of claim 8 , wherein the controller is configured to automatically deliver the modified insulin delivery pattern.

15. The system of claim 8 , wherein the controller is further configured to present a recommendation to modify the insulin delivery pattern on a user interface and to deliver the modified insulin delivery pattern only after receiving a confirmation in response to the recommendation.

16. The system of claim 8 , wherein the controller is further configured to provide a notification to the user regarding the modification to the insulin delivery pattern.

17. The system of claim 8 , wherein the controller, the input and the pump are part of a common device.

18. The system of claim 8 , wherein the controller and the input are part of a handheld device that is separate from the pump.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2019
From: SMITHS MEDICAL ASD, INC.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 050305/0848 →
MERGER Recorded Sep 5, 2019
From: SMITHS MEDICAL MD, INC.
To: SMITHS MEDICAL ASD, INC.
Reel/Frame 050285/0503 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2019
From: BLOMQUIST, MICHAEL
To: SMITHS MEDICAL MD, INC.
Reel/Frame 050267/0561 →
Cited By (1)
US 12,431,104